Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2011 by Hadassah Medical Organization.
Recruitment status was Not yet recruiting

Sponsor:

Collaborator:

DIABETES UNIT

Information provided by:

Hadassah Medical Organization

ClinicalTrials.gov Identifier:

NCT01281072

First received: January 20, 2011

Last updated: NA

Last verified: January 2011

History: No changes posted

Purpose

Open label study to evaluate long term treatment effect of diapep277.

Condition	Intervention	Phase
Giving a Vaccination in Three Months	Other: vaccine	Phase 3

Study Type:	Interventional
Study Design:	Intervention Model: Single Group Assignment

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:

Eligibility

Ages Eligible for Study:	20 Years to 50 Years
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

1. patient that completed 901 and 910 study.

Exclusion Criteria:

1. cpeptide<0.2

Contacts and Locations

No Contacts or Locations Provided

More Information

No publications provided

Responsible Party:	PROP ITAMAR RAZ, HADASSAH MEDICAL CENTER
ClinicalTrials.gov Identifier:	NCT01281072 History of Changes
Other Study ID Numbers:	911-DIAPEP277
Study First Received:	January 20, 2011
Last Updated:	January 20, 2011
Health Authority:	Israel: Ministry of Health

ClinicalTrials.gov processed this record on May 19, 2013